幼年皮肌炎血清深度蛋白质组学分析揭示与肌炎特异性自身抗体相关的蛋白表达
该研究采用数据非依赖采集模式的单次液相色谱-串联质谱,分析抗MDA5抗体(n=5)、抗NXP2抗体(n=5)、抗TIF1-γ抗体(n=5)阳性幼年皮肌炎患者及健康对照(n=5)的血清蛋白。共检测到2413种蛋白,其中508种在肌炎特异性自身抗体组中共同改变;仅在抗MDA5抗体组中I型干扰素和蛋白酶体通路显著上调。作者认为血清蛋白谱可能有助于开发治疗靶分子和生物标志物。
要点
- 血清质谱检测到2413种蛋白,508种在三种肌炎特异性自身抗体组中共同改变。
- 仅在抗MDA5抗体组中I型干扰素和蛋白酶体通路显著上调。
- 作者认为与肌炎特异性自身抗体相关的血清蛋白谱可能有助于开发治疗靶分子和生物标志物。
核心结论
- 幼年皮肌炎血清含有多种在肌炎特异性自身抗体组中共同改变的蛋白,但与抗体相关临床特征的通路因蛋白积累而异。
- 作者认为与肌炎特异性自身抗体相关的深度血清蛋白谱可能有助于开发治疗靶分子和生物标志物。
研究设计与样本
- 研究分析了抗MDA5抗体阳性(n=5)、抗NXP2抗体阳性(n=5)和抗TIF1-γ抗体阳性(n=5)的幼年皮肌炎患者血清,以及健康对照(n=5)。
- 采用数据非依赖采集模式的单次液相色谱-串联质谱进行蛋白质组学分析。
- 研究者按肌炎特异性自身抗体分组识别不同蛋白群,并进行通路分析以理解其特征。
主要发现
- 血清质谱分析共检测到2413种蛋白。
- 508种蛋白在肌炎特异性自身抗体组中共同改变,包括许多肌源性酶和干扰素调节蛋白。
- 使用各肌炎特异性自身抗体组中上调前50种蛋白进行通路分析显示,I型干扰素和蛋白酶体通路仅在抗MDA5抗体组中显著上调。
关键数值与推荐
- 抗MDA5抗体阳性组n=5,抗NXP2抗体阳性组n=5,抗TIF1-γ抗体阳性组n=5,健康对照组n=5。
- 血清质谱分析检测到2413种蛋白,其中508种在肌炎特异性自身抗体组中共同改变。
- 通路分析采用各肌炎特异性自身抗体组中上调前50种蛋白,仅抗MDA5抗体组中I型干扰素和蛋白酶体通路显著上调。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The clinical symptoms and complications of JDM differ depending on the type of muscle-specific autoantibodies (MSAs) present. We aimed to identify protein expression profiles specific for MSAs that characterize various clinical features by comprehensively analyzing the proteins present in the serum of patients with JDM. METHODS: We analysed sera from patients with JDM that were positive for anti-melanoma differentiation-associated protein 5 (MDA5) antibodies (n = 5), anti-nuclear matrix protein 2 (NXP2) antibodies (n = 5) and anti-transcriptional intermediary factor 1 alpha or gamma subunit (TIF1-γ) antibodies (n = 5), and evaluated healthy controls (n = 5) via single-shot liquid chromatography-tandem mass spectrometry (MS) in data-independent acquisition mode, which is superior for comparative quantitative analysis. We identified different protein groups based on MSAs and performed pathway analysis to understand their characteristics. RESULTS: We detected 2413 proteins from serum MS analysis; 508 proteins were commonly altered in MSAs, including many myogenic enzymes and IFN-regulated proteins. Pathway analysis using the top 50 proteins that were upregulated in each MSA group revealed that the type I IFN and proteasome pathways were significantly upregulated in the anti-MDA5 antibody group alone. CONCLUSION: Although JDM serum contains many proteins commonly altered in MSAs, the pathways associated with clinical features of MSAs differ based on protein accumulation. In-depth serum protein profiles associated with MSAs may be useful for developing therapeutic target molecules and biomarkers.
引用
- Sato H, Inoue Y, Kawashima Y, et al. In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies. Rheumatology (Oxford). 2023. PMID: 37052527. doi:10.1093/rheumatology/kead165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。